When to stop surveillance of incidental pancreatic cysts and liver cancer in older adults

Design

Expert review with best-practice advice statements, no formal evidence rating

Population

Older adults with incidental pancreatic cystic lesions or with cirrhosis at risk of hepatocellular carcinoma

Primary outcome

Advice on when to stop imaging surveillance

Effect

Consider stopping at 5 years of stability for small cysts; stop HCC surveillance when life expectancy is under 1 to 2 years

This expert review, commissioned by a gastroenterology society, was drawn from the literature and expert opinion without a systematic review, so its advice statements carry no formal grade of evidence.

It advises counselling against routine cyst surveillance in people with significant comorbidity, particularly for low-risk cysts. In people over 65 with cysts of 15 mm or less that have been stable for five years, with no worrisome features, stopping should be considered after shared decision-making. For those over 75 with cysts under 30 mm stable for five years, the value of continuing should be discussed. For hepatocellular carcinoma, surveillance should be considered in older adults with cirrhosis from any cause, and should stop when life expectancy is under one to two years.

These statements are an expert opinion, not a change to guidelines for fitter patients. For radiology, the point is that follow-up recommendations in reports can include an end point.

• Consider adding a stopping point to follow-up recommendations for small, stable pancreatic cysts in older patients.
• Discuss with the referrer before recommending open-ended surveillance in patients with significant comorbidity.
• Define stability: growth of 3 mm or more a year, or 6 mm or more in two years, was treated as concerning.
• Keep surveillance in fitter patients with worrisome features or high-risk stigmata, per the usual guidelines.
• Remember that this advice rests on expert opinion rather than trial data.

Why it matters

Open-ended surveillance can outlast its usefulness, and imaging recommendations in reports are often where it starts.

Don't overread it

Expert opinion without systematic review or evidence grading; it does not replace the existing guidelines for fitter patients.

The statistics, in plain English

No numbers here come from a trial. The thresholds, such as five years of stability and cyst size cut-offs, are judgements that balance the small chance of cancer against the risks and anxiety of ongoing imaging and intervention.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.